Search





Search





Markets
/
Stocks
/
catx
/

Perspective Therapeutics Inc

CATX

Add to Watchlist

2.940USD

-0.010-0.34%

Market hours （ET）Quotes delayed by 15 min

218.55MMarket Cap

LossP/E TTM

Perspective Therapeutics Inc

2.940

-0.010-0.34%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-23

Previous score

5.00

Change

The current institutional shareholding score of Perspective Therapeutics Inc is 5.00, ranking 132 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 54.19%, representing a quarter-over-quarter decrease of 34.77%. The largest institutional shareholder is Paul Tudor Jones, holding a total of 34.03K shares, representing 0.03% of shares outstanding, with 0.67% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Lantheus Holdings, Inc.

11.68M

TCG Crossover Management, LLC

7.92M

Qatar Investment Authority

7.07M

Commodore Capital LP

6.34M

Avidity Partners Management LP

6.05M

+88.43%

BlackRock Institutional Trust Company, N.A.

4.21M

+4.79%

Morgan Stanley & Co. LLC

3.38M

+28.95%

Two Sigma Investments, LP

1.86M

+101.28%

Nicholson Wealth Management Group, LLC

1.62M

-0.02%